Dalian Medical University
11
1
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Bispectral-Electroencephalography (EEG) in First Time Hemodialysis
Role: collaborator
Construction of a Predictive Model of Gangrenous Cholecystitis Based on Machine Learning
Role: lead
Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.
Role: lead
Prevalence and Risk Indicators of Peri-implant Diseases in China
Role: collaborator
Mindray Neuromuscular Transmission Transducer
Role: collaborator
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
Role: collaborator
A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female
Role: collaborator
The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study
Role: collaborator
Effect of Cemented Implantation in Shoulder Replacement on Blood Pressure
Role: collaborator
Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China
Role: collaborator
Efficacy and Safety Study of Catheter Ablation for Atrial Fibrillation
Role: collaborator
All 11 trials loaded